Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Indivior ( (GB:INDV) ) just unveiled an announcement.
Indivior PLC has announced the repurchase and cancellation of 222,704 of its ordinary shares as part of its $100 million Share Repurchase Program. This strategic move reduces the total number of shares in circulation to 124,440,149, which may affect shareholders’ notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. The repurchase is expected to enhance shareholder value and reflects the company’s commitment to optimizing its capital structure.
More about Indivior
Indivior PLC is a pharmaceutical company specializing in the development and commercialization of medications to treat addiction and mental health disorders. The company focuses on providing innovative treatments that address unmet medical needs in the global market.
YTD Price Performance: -6.69%
Average Trading Volume: 317,926
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.19B
See more insights into INDV stock on TipRanks’ Stock Analysis page.
